P-185 - CYP2C19 METABOLIZER PHENOTYPE INFLUENCES SERTRALINE PHARMACOKINETICS IN CHILDREN AND ADOLESCENTS.

S. Vaughn^1,2, E. Poweleit^2,3, Z. Desta⁴, J. Strawn^2,3, L. Ramsey^1,2; ¹Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA, ²University of Cincinnati, Cincinnati, OH, USA, ³Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA, ⁴Indiana University, Indianapolis, IN, USA.